ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "S01L" (26)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Verteporfin (S01LA01) 1 products WHO-DDD DrugBank.ca 
L IPCI Visudyneampoule(s)1048.961157.2010 %Lyophilisate: Verteporfinum 15 mgCheplapharm Schweiz
GmbH		A / SLG
Ranibizumab (S01LA04) 10 products WHO-DDD DrugBank.ca 
L IP  Byooviz 10 mg / mL 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlSamsung Bioepis CH
GmbH		B / SLG
L IP  Ranivisio 10 mg/mL 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlBioeq AGB / SLG
L IP  Ximluci 10 mg/ml 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlSpirig HealthCare AGB / SLG
LSIPIPCI LucentisDurchstechflasche(n) à 0.23 ml611.09673.0520 %Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		B / SLG
L IP  LucentisFertigspritze(n)611.09673.0520 %Injektionslösung zur intravitrealen Injektion in Fertigspritze: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		B / SLG
 SIPIPCI LucentisDurchstechflasche(n) à 0.23 mlk.A.Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		BG
  IP  Byooviz 10 mg / mL k.A.Injection solution: Ranibizumabum 10 mg/mlSamsung Bioepis CH
GmbH		BG
  IP  Ximluci 10 mg/ml k.A.Injection solution: Ranibizumabum 10 mg/mlSpirig HealthCare AGBG
  IP  Ranivisio 10 mg/ml k.A.Injection solution in prefilled syringe: Ranibizumabum 10 mg/mlBioeq AGG
 SIPIPCI LucentisDurchstechflasche(n) à 0.23 ml874.341020.15k.A.Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		BG
Aflibercept (S01LA05) 13 products WHO-DDD DrugBank.ca 
L IP  Eylea, 2 mg/0,05 mlDurchstechflasche(n)500.00563.2510 %Injection solution: Afliberceptum 2mg / 0.05mlBayer (Schweiz) AGB / SLG
L IP  Eylea 8 mg/0.07 ml 500.00560.2010 %Injection solution: Afliberceptum 8mg / 0.07mlBayer (Schweiz) AGB / SLG
L IP  Pavblu 40 mg/ml 417.33478.4510 %Injection solution: Afliberceptum 2mg / 0.05mlAmgen Switzerland AGB / SLG
L IP  Afqlir 40 mg/ml 417.33478.4510 %Injection solution in prefilled syringe: Afliberceptum 2mg / 50µlSandoz
Pharmaceuticals AG		B / SLG
L IP  Eylea 8 mg/0.07ml 500.00560.2010 %Injection solution in prefilled syringe: Afliberceptum 8mg / 0.07mlBayer (Schweiz) AGB / SLG
L IP  Pavblu 40 mg/ml 417.33478.4510 %Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05mlAmgen Switzerland AGB / SLG
L IP  Eylea 2 mg/0.05 ml 500.00563.2510 %Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µlBayer (Schweiz) AGB / SLG
  IP  Aflivis 40 mg/ml k.A.Injection solution: Afliberceptum 2mg / 50µlOmniVision AGBG
  IP  Afqlir 40 mg/ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlSandoz
Pharmaceuticals AG		BG
     Yesafili 40 mg/ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlMedius AGBG
  IP  Aflivis 40 mg/ml k.A.Injection solution in prefilled syringe: Afliberceptum 2mg / 50µlOmniVision AGBG
     aflibercept HORUS 40 mg/ ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlHorus Pharma Suisse SABG
  IP  Eylea 2 mg/0.05 mlsyringe(s)913.481063.35k.A.Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µlBayer (Schweiz) AGBG
Brolucizumab (S01LA06) 1 products WHO-DDD  
L IP  Beovu 120mg/1ml 652.91726.5010 %Injection solution in prefilled syringe: Brolucizumabum 120 mg/mlNovartis Pharma
Schweiz AG		B / SLG
Faricimab (S01LA09) 1 products WHO-DDD  
L IP  Vabysmo 6 mg/0.05 ml 796.10882.2010 %Injection solution in prefilled syringe: Faricimabum 6mg / 0.05mlRoche Pharma
(Schweiz) AG		B / SLG
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home